The government is making an increasing number of expensive life-saving or life extending drugs and devices available to more people, but is that the right thing to do and can we afford it, anyway?
Health care is an emotional subject for many Americans — and often one of extremes. Yet, as we obssess about the system's structure and cost, we neglect our own health. Obesity and high blood pressure are more common, while exercise and diet are overlooked. Our special report, "Healthy Business", explores these issues.
More and more American women are seeking infertility treatment to increase their chances of having a child, but there's been no change in success rates and costs remain high, even with health insurance coverage.
Expected government cuts to Medicare and Medicaid, the uncertainty of health care reform and looming patent expirations are weighing heavily on the outlook of the biggest companies in the sector: large-cap pharmaceutical stocks.
Manufacturers are delivering an ever growing roster of exercise games and interactive fitness technology to health clubs, YMCAs, park, recreation centers and even schools.
Among the crowded ranks of healthy food trends -- quinoa, farm-to-table, whole whole grains — one food category is growing into a genuine, industry juggernaut: gluten-free.
Health-conscious U.S. consumers are buying hundreds of millions of dollars of so-called superfruits annually, even as critics contend their nutritional benefits are overblown and, in some cases, nonexistent.
The Centers for Disease Control considers obesity in America an epidemic; more than one out of three adults and 17 percent of all children are technically overweight to the point of obesity.
American spends more on health care than any other country. Do you know where it goes?
Biotechs are addicted to capital like "crack addicts are addicted to crack," because of the $1 billion-plus price tag that it takes to bring a drug to market, Gregory Brown, founder and managing director of Cowen Healthcare Royalty Partners, told CNBC Monday.
Expensive, aggressive treatments are often superior to other alternatives, but, too often, we confuse expensive and aggressive treatments with effective ones. No treatment path is risk-free, and every treatment carries the risk of flawed execution by the physician or the patient, which creates new and sometimes greater risks.
Breaking down the anticipated healthcare costs for retirees, with Brad Kimler, Fidelity Investments executive vice president.
Insight on why now is the right time to invest in biotech stocks, with Dr. Mark Monane, Needham & Co. biotech analyst.
To receive Federal stimulus money for the implementation of electronic medical records, hospitals and physicians must satisfy the “meaningful use” criteria as defined by the Department of Health and Human Services. Although Stage 1 criteria appear to be more of a checklist of how to use these systems, subsequent stages will be more complex and difficult to satisfy, thereby putting into jeopardy the continued qualification for these funds by hospitals and physicians.
It's been one year since President Obama signed the health care bill, and health care stocks have done pretty well. And a look at Research in Motion ahead of tomorrow's earnings announcement, with Colin Gillis, BGC Partners, CNBC's Melissa Lee and the Fast Money traders.
CNBC's Bertha Coombs interviews Dr. Henry Feldman about using the iPad and how it has changed the way he and his fellow doctors interact with patients at Boston's Beth Israel Deaconess Medical Center.
How do you know that 2010 was a good year for Wall Street? That male-dominated world can now afford facelifts to remove worry lines etched in when business dove and bonuses disappeared.
Cramer offers up a medical opinion for those who feel their portfolio is under the weather.
You can promote yourself online and seek donations or donate parts of your body for hefty fees.
An estimated half a million American seniors have moved overseas to retire, and that number is growing. Some relocate abroad to get a bigger bang for their ever-shrinking retirement buck. Others go in search of adventure.